Article
Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
BMC cancer - 19 Jun 2017
van Ginkel Joost H, Huibers Manon M H, van Es Robert J J, de Bree Remco, Willems Stefan M
Abstract excerpt
BACKGROUND: During posttreatment surveillance of head and neck cancer patients, imaging is insufficiently accurate for the early detection of relapsing disease. Free circulating tumor DNA (ctDNA) may serve as a novel biomarker for monitoring tumor burden during posttreatment surveillance of these patients. In this exploratory study, we investigated whether low level ctDNA in plasma of head and neck cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
